drugset / Trial / NCT00667225
Efficacy of Cantharidin in Molluscum Contagiosum
Completed
29 enrolled
University of North Carolina, Chapel Hill
Doris Duke Charitable Foundation · collabNational Center for Research Resources (NCRR) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The University of North Carolina Department of Dermatology is conducting a clinical trial to evaluate a drug called cantharidin in the treatment of molluscum contagiosum. Molluscum is a common dermatologic disorder caused by a poxvirus. Molluscum typically presents with many flesh-colored bumps on the skin. It goes away on its own, though can last several months to several years. Cantharidin is a topical medicine which is applied at the clinic visit. It is well tolerated by the majority of children.
Timeline
- Start
- 2008-01
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cantharidin | Small molecule | 0.7 % | Topical |